Form 8-K - Current report:
SEC Accession No. 0000950170-22-016905
Filing Date
2022-08-11
Accepted
2022-08-11 16:25:18
Documents
13
Period of Report
2022-08-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K aura-20220811.htm   iXBRL 8-K 57837
2 EX-99.1 aura-ex99_1.htm EX-99.1 313277
  Complete submission text file 0000950170-22-016905.txt   507079

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aura-20220811_pre.xml EX-101.PRE 10293
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aura-20220811_lab.xml EX-101.LAB 14010
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aura-20220811.xsd EX-101.SCH 2478
7 EXTRACTED XBRL INSTANCE DOCUMENT aura-20220811_htm.xml XML 4959
Mailing Address 85 BOLTON STREET CAMBRIDGE MA 02140
Business Address 85 BOLTON STREET CAMBRIDGE MA 02140 (617)500-8864
Aura Biosciences, Inc. (Filer) CIK: 0001501796 (see all company filings)

EIN.: 320271970 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40971 | Film No.: 221156253
SIC: 2836 Biological Products, (No Diagnostic Substances)